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Abstract
Biomarkers for the prediction of vasospasm and delayed cerebral ischemia in patients
with a ruptured cerebral aneurysm could be helpful.
In this prospective clinical study, endothelin-1, lactate, pCO2, and pO2 were measured in
arterial and internal jugular vein blood before, during and after surgical treatment of a
cerebral aneurysm, and were tested as potential predictors of neurologic outcome in
patients.
Forty-one patients were enrolled in the study, 23 of them were operated on after
aneurismal rupture with development of subarachnoid hemorrhage (SAH) and 18 patients
were operated on for a nonruptured aneurysm.
All of the involved patients survived. There was no difference in neurologic outcome
between those operated on with a ruptured or nonruptured aneurysm.
Endothelin-1 and lactate concentrations as well as pO2 and pCO2 from arterial and venous
blood samples and their venoarterial difference did not differ between groups with and
without an aneurismal rupture. Venoarterial difference of endothelin-1 concentrations on
the day after surgery significantly differed between the groups with favorable and
nonfavorable neurologic outcome. Other variables did not show a statistically significant
difference.
Significant correlation was found between endothelin-1 and lactate concentrations,
suggesting involvement of the same pathophysiological process.
Another interesting finding was lower arterial and venous pCO2 in patients with lower
initial Glasgow Coma Scale (GCS) score and higher Hunt Hess score in the phase after
extubation.
We can conclude that the measured biochemical parameters did not show sufficient
predictive power to be useful for prediction of cerebral vasospasm and neurologic
outcome in everyday clinical practice. However, some correlations that do exist between
them suggest involvement of the same pathophysiological process.
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Introduction
Subarachnoid hemorrhage (SAH) is a dramatic event with a rapid rise in intracranial
pressure. Severe headache, nausea, vomiting, double vision, and nuchal rigidity,
eventually accompanied by seizures are the usual clinical presentation. Furthermore, loss
of consciousness and even death can occur. Signs of meningeal irritation are often
positive. Incidence of SAH is 7-13/100000 of population per year. (1-5) Incidence of
cerebral aneurysm is around 1.8 to 2 %. (6-8) Mortality from a ruptured cerebral
aneurysm and development of SAH is rather high, around 50%. (9) Approximately 10% of
patients die before reaching hospital, 25 % die in the first 24 hours, and another 25% die
in the first month after rupture, usually due to recurrent bleeding. (10) Risk of recurrent
bleeding in the first 24 hours after aneurismal rupture is between 2.6 to 4%. (11,12) The
majority (73%) of recurrent bleeding occurs in the first 3 days after rupture. (13)
In addition, patients with SAH can also develop delayed cerebral ischemia. It is explained
mainly by the development of cerebral vasospasm. Clinical manifestations of these events
are impaired consciousness and focal neurologic deficits.
Literature data about the incidence of cerebral vasospasm in patients with ruptured
cerebral aneurysm and SAH vary in the range of 1.5 to 91% which demonstrates the
diagnostic difficulties when different methods and different definitions are used. (14,15)
In general the incidence could be considered around 20-30%. (16) An up-to-date uniform
method for definition and classification of cerebral vasospasm has not been established
yet. (17)
Cerebral angiography could be chosen as the gold standard for the recognition of cerebral
vasospasm, but it provides insight into spasm of large arteries only and cannot show the
state of the microcirculation. An association between diffuse angiographic vasospasm and
patient outcome has not been found. (15) Repeated angiography for vasospasm
monitoring in patients with SAH is not appropriate. Some authors suggest serial exams
using transcranial Doppler to detect development of cerebral vasospasm. (18,19) However,
a higher velocity of blood flow is not always seen in patients with cerebral vasospasm.
Surprisingly, reduced blood flow can be found in some patients, compromising the
transcranial Doppler as a unique method in diagnosing and monitoring of cerebral
vasospasm. (17)
Despite its imperfection, clinical assessment is often used as a method for estimation of
the presence of cerebral vasospasm. (20) Clinical judgement has been shown to be
superior in the prediction of cerebral ischemia and its consequences compared to
angiography or transcranial doppler (TCD) defined cerebral vasospasm. (21) Subjectivity
and difficulties in the clinical assessment of consciousness in sedate and anesthetized
patients, as well as low sensitivity for subtle changes in consciousness remain the main
weaknesses of this method. (21,22)
The main goal of surgical intervention is prevention of recurrent bleeding. Cerebral
vasospasm is usually not present in the first three days after the aneurismal rupture. It
develops typically between the 4th and 14th day after rupture. (9) According to some
authorities, surgical intervention should not be performed in the presence of vasospasm,
instead, it should be either done earlier, in the first three days after the rupture, or it
should be delayed for two weeks after the rupture. It could be supposed that cerebral
vasospasm is already resolved two weeks after the rupture.
Additional biochemical markers of cerebral vasospasm and cerebral ischemia could be
helpful in routine clinical practice. In the case of cerebral vasospasm, hyperventilation
during surgical intervention should be avoided. According to some authors, blood
oximetry of samples obtained from the jugular bulb during the operation can provide
information about the presence of cerebral ischemia. (23-25) Lower oxygen saturation of
hemoglobin is associated with higher oxygen release in ischemic areas of the brain, which
are developed by vasospasm.
Lactate is a product of anaerobic metabolism and is a well known marker of tissue
ischemia. Measurements of lactate concentrations in the jugular vein and comparison
with concentrations in arterial blood could potentially provide an insight into the amount
of energy produced in the brain by anaerobic metabolism. (26, 27)
Pathogenesis of cerebral vasospasm is not completely clear. It is supposed that degraded
products of blood induce vasoconstriction of arteries in the cerebrospinal space.
Endothelin released from the intimal layer of blood vessels is a potent vasoconstrictor.
Several experimental studies as well as some clinical studies demonstrated its potential
role in the development of cerebral vasospasm. (28-31) Still, there are several studies
which could not confirm this finding. (32-34)
In our study, concentrations of endothelin-1, lactate, and partial pressures of oxygen
(PO2) and carbon dioxide (pCO2) were tested in arterial and jugular vein blood as
predictors of outcome and potential markers of cerebral vasospasm and ischemia in
patients who underwent operation of cerebral aneurysm.
Patients and methods
The study was approved by the Clinical Hospital Centre Zagreb Ethics Committee.
Patients who underwent neurosurgical operation of a cerebral artery aneurysm were
considered eligible for enrollment in this prospective study. Inclusion criteria were:
inform consent signed by the patient or close relative and availability of the investigator
during the operative procedure. The patients were divided into two groups: group 1 with a
ruptured cerebral aneurysm and group 2 with a nonruptured cerebral aneurysm. The
latter represent the control group.
For preoperative sedation all patients received midazolam intramuscularly. Thiopental
was used in a dose of 3-6 mg/kg of body weight and fentanyl in a dose of 0.5-9 ug/kg for
induction of anesthesia and intubation. Muscle relaxants, vecuronium or pancuronium,
were given at a dose of 0.1 do 0.15 mg/kg and recuronium at a dose of 0.6 do 1.2 mg/kg.
For maintenance of anesthesia, tiopental and fentanyl drip were used. Target systolic
blood pressure, till clamping of aneurysm, was 95-100 mmHg.
After clamping of the aneurysm, reasonable triple H therapy (hemodilution, hypertension
and hypervolemia) was conducted in all patients. Dosage was individualized during the
operation by the attending anesthesiologist and in the intensive care unit after the
operation. Target hematocrit was 33-38%, target central venous pressure was 5-12 mmHg,
and target systolic blood pressure was 130-200 mmHg.
Continuous intravenous nimodipine was included in the postoperative period if the
systolic blood pressure exceeded 140 mmHg, and its dosage was titrated until target
systolic blood pressures were reached. Maximal dose of nimodipine was 2 mg/h. Normal
saline infusion was used to keep patients optimally hydrated or mildly hyperhydrated.
Simultaneous blood samples for laboratory analysis were obtained from the radial artery
and from the jugular vein bulbus in all patients. Samples were taken: after induction of
anesthesia, before the operation, after opening the dura mater, 5 minutes after clamping
of the aneurismal neck, 30 minutes after aneurismal clamping, after postoperative arrival
in the intensive care unit, after awakening, after extubation and on the day after the
operation. Blood gases and lactate concentrations were measured in all samples.
Endothelin-1 concentrations were measured in samples obtained before the beginning of
the surgical procedure, during the operation (30 minutes after clamping of the aneurismal
neck) and the next morning after the operation.
Neurologic state was followed and recorded using the Hunt Hess scale. State of
consciousness was assessed using the Glasgow Coma Scale (GCS), (35-37) before
induction of anesthesia, every hour during the first 24 hours after the operation, and daily
in the later postoperative period. Evaluation of motoric deficit was performed before the
operation, after recovery from general anesthesia and 6 months after the operation.
Glasgow Coma Scale of 14 or lower, as well as worsening of motoric deficit, were the main
criteria for diagnosis of delayed cerebral ischemia and cerebral vasospasm, after other
possible causes were excluded. (38) Investigators who evaluated state of consciousness
and motoric deficit were “blind” to the laboratory results.
A modified Marbach–Weil method (“Dade Behring, Dimension Clinical Chemistry
System”) was used for the measurements of blood lactate concentrations using “Lactic
Acid Flex” reagents. (39,40)
Endothelin-1 concentrations were measured by ELISA method (“Biomedical Assays”).
PCO2 in blood was measured by potentiometry and PO2 in blood by amperometry (GEM
Premier 3000).
Functional outcome was measured by modified Rankin scale 6 months after the operation.
When Rankin score was 3 or higher, the outcome was classified as poor. (41-43)
Statistical analysis was performed using MedCalc Software version 12.1.3. (Mariakerke,
Belgium).
Numerical variables were tested for the normality of distribution using Kolmogorov-
Smirnov test and were presented as mean ± standard deviation or median (interquartile
range) as appropriate. T test was used to compare normally distributed variables, and
ANOVA was used to explore the difference among more than two subgroups (Hochberg’s
test for post hoc analysis). Kruskal-Wallis test was used to explore the difference between
more than two variables that were not distributed normally. Nonparametric Mann-
Whitney U-test was used to compare the difference between two subgroups with no
normally distributed variables.  To compare the difference in proportions, Pearson’s χ2
and χ2 for post hoc analysis were used. Fisher’s test was used in case of small sample size.
To determine the correlation between two continuous variables Spearman’s rho test was
used. P value <0.05 was considered significant.
Results
Over a period of two years, 144 patients underwent surgery for a cerebral artery aneurysm.
Forty-one consecutive patients from this group were enrolled in the study. The selection
depended on the availability of the investigator during the surgical procedure and
patients’ consent to be included in the study.
There were 30 females (73.2%) and 11 males (26.8%). By binominal test, females were
significantly more common (P=0.003).
In 31 patients (75.6 %), the aneurysm was present on one of the cerebral arteries, whereas
in 10 (24.4%) patients, aneurysms were found on more than one artery.
In 23 (56.1%) patients, the operation was performed after aneurismal rupture and
development of SAH, while in 18 (43.9%) patients a nonruptured aneurysm was
discovered coincidentally, and the operative procedure was elective.
There was no difference between these two groups according to age, gender, and mean
arterial pressure before, during and after the operation (table 1).
Patients with a nonruptured aneurysm awakened significantly earlier after the operation
and were extubated earlier than those operated on after aneurysm rupture and SAH
development. The amount of thiopental administered during the operation was somewhat
larger in the group with SAH but the statistical significance was borderline. Frequency of
neurologic deficits did not differ between groups. There was no difference in Glasgow
outcome scale (GOS) and Rankin outcome scale between these two groups in the
postoperative period, as well as 6 months after the operation.
Analysis of blood samples obtained before aneurysm clamping, 5 and 30 minutes after
clamping, at arrival to the intensive care unit (ICU) after the operation, at the moment of
awakening, at the moment of extubation and the next day after the operation, did not
show significant differences in blood gases, lactate and endothelin-1 values between the
two groups.There was some statistically significant, but clinically irrelevant, difference in
the results of blood gas analysis. Comparison of the groups with favorable and unfavorable
outcome for arteriovenous difference in lactate concentration on the day after the
operation, showed a higher difference in the group with a unfavorable outcome (table 2).
There were also statistically significant differences in pCO2 during the operation and
immediately after the operation showing lower pCO2 in the group with an unfavorable
neurologic outcome. Other measured parameters did not differ significantly between these
two groups.
Several correlations were found using Spearman rho statistical test. There was a clear
correlation between venoarterial difference of lactate concentrations in samples obtained
30 minutes after aneurismal clamping and initial GCS and Hunt Hess score. The same
correlation was found with almost all GCS scores after general anesthesia, assessed every
hour after the operation (table 3).Thus, such a correlation could not be found for absolute
lactate concentrations from arterial and venous blood samples. This finding point out that
there is higher lactate production, during the operation, in brains of patients with a lower
GCS.
Higher venoarterial difference in lactate concentrations before induction of anesthesia
was associated with lower initial GCS, as well as with lower GCS 21 hours and 2 days after
operation.
Significant correlation was found between the following scores and pCO2: Hunt Hess
before surgery, GCS score before and after the operation and pCO2 in venous and arterial
blood samples obtained at the time of extubation and on the morning after the operation
(table 3).
PCO2 found in arterial and venous blood before the operation was not in correlation with
GCS before and after the operation.
In the entire population of patients operated on for cerebral aneurysm a positive
correlation was observed between concentrations of endothelin-1 before the operation and
arterial blood lactate before the operation, as well as in samples taken 5 and 30 minutes
after clamping of the aneurysm. However, when only observing the group of patients with
a ruptured aneurysm, no correlation between endothelin-1 and lactate concentrations was
demonstrable (table 4).
The correlation between endothelin-1 concentrations and venoarterial difference of
endothelin-1 concentrations and Hunt Hess and GCS scores was not found in all samples.
No significant correlation between endothelin-1 concentration and pCO2 or pO2 values
was found, except for correlation between venoarterial difference in endothelin-1
concentration and pCO2 in venous and arterial blood after the operation, at the time when
patients were transferred to the ICU (rS 0,445, P=0.04).
There was positive correlation between endotelin-1 concentrations in the jugular vein
before the operation and hours until recovery of consciousness from general anesthesia.
Patients with higher endotelin-1 needed more time to wake spontaneously.
Positive correlation was also found between the time period in hours from rupture to
operation and endothelin-1 concentrations in the jugular vein before patients were
operated.
The population of patients operated on 3 or less days after aneurismal rupture had
significantly higher endothelin-1 concentrations in the jugular vein before the operation
compared to those operated later (rS=0,516; P=0,034). This however was not shown if the
population with SAH was analysed.
There is a correlation between lactate concentrations in the vein and artery and the time
of extubation (arterial lactate rS=0,346; P=0,029, venous lactate rS=0,490; P=0,001).
No correlation between GOS and Rankin score and some of measured biochemical
parameters was found.
Discussion
The Eetiology of cerebral ischemia in cerebral aneurysm rupture is multifactorial. Arterial
vasospasm is supposed to play the main role, still, impairment of autoregulation of
cerebral blood flow, presence or absence of collateral circulation, possible spasm of small
vessels, platelets aggregation, as well as negative side effects of angiography and the
surgical procedure may also have a significant role. (21,44-48)
It is difficult to estimate the real incidence of cerebral vasospasm due to lack of a uniform
definition, adequate diagnostic method and clear understanding of the pathophysiologic
mechanism of spasm of cerebral arteries and changes in the microcirculation. Despite all
these weaknesses, the clinical definition of cerebral vasospasm is one of the most
commonly used. Nevertheless, clinical diagnosis of delayed cerebral ischemia is
retrospective and is therefore not useful in clinical practice, where the main goal is to
prevent this event. A series of biochemical markers of neuronal degradation products were
tested and none of them proved to be a powerful marker of cerebral vasospasm and
delayed cerebral ischemia. A palette of them combined is shown to be somewhat more
reliable. Since all of them are markers of already developed neuronal damage, detection of
mediators of vasoconstriction and ischemia that precede neuronal damage would be of
significant interest to guide the treatment and to avoid cerebral damage.
In this study potential biomarkers for detection of cerebral ischemia such as: oxygen
extraction and production of carbon dioxide and lactate in the brain tissue were tested
together with endothelin-1, a peptide which probably plays a role in the development of
cerebral vasospasm.
In this study there was no significant difference in endothelin-1 concentrations between
the groups of patients operated due to ruptured and nonruptured cerebral aneurysm.
Venoarterial difference in endothelin-1 concentrations differed significantly on the day
after the operation between groups of patients with a favorable and unfavorable
neurologic outcome. Endothelin-1, analysed in samples before and during the operation of
cerebral aneurysm, did not differ significantly between these two groups. When the
population of patients, operated in the first 3 days after the aneurismal rupture, was
analysed, there was a positive correlation of endothelin-1 levels found in the samples
obtained at the time of induction of anesthesia and the time from rupture to operation.
These observations show that patients with a ruptured aneurysm and SAH experience a
rise of endothelin-1 in the first several days, which corresponds to the usual delay for
cerebral vasospasm to develop.
Interesting, is also the finding of a positive correlation between endothelin-1
concentrations before surgery and blood lactate in serial samples later. This indicates that
endothelin-1 and lactate are both involved in the same pathophysiological process of
delayed cerebral ischemia, which can determine the patient’s outcome. The most logical
explanation is that there is higher lactate production in ischemic brain tissue. Brain
ischemia is provoked by vasospasm which could be mediated by endothelin-1, a potent
vasoconstrictor. Still, other explanations are also possible.
A negative correlation between GCS before the operation and venoarterial difference in
lactate concentration at the same time, suggests a higher lactate production in the brain of
patients with a lower GCS. Positive correlation of endothelin-1 levels measured at the time
of induction of anesthesia and the time period from rupture to operation was observed in
the population of patients operated on in the first 3 days after the aneurismal rupture.
This was no longer present if all patients operated on after aneurismal rupture were
included. Such an observation is in concordance with current knowledge about
endothelin-1 concentrations rising in the first few days after rupture. (28,49,50)
At the moment of awakening from general anesthesia, a lower pCO2 in the jugular vein
was found in the group of patients operated on after aneurismal rupture compared to the
group operated on for a nonruptured cerebral aneurysm. A similar result was observed if
the group of patients with supposed cerebral vasospasm and the group without it were
compared, yet only with a borderline statistical significance. Also, lower pCO2 was found
both in arterial and venous blood in the group of patients operated on after aneurismal
rupture in samples obtained at the moment of extubation and on the next day. There is
also a clear correlation between lower postoperative GCS and lower pCO2 in arterial and
jugular vein blood after the operation. CO2 is a product of aerobic metabolism, so lower
pCO2 production in ischemic tissue could be expected. But, other factors such as blood
flow can theoretically also influence pCO2 in venous blood. Lower arterial and
consequently venous pCO2 is best explained by spontaneous higher lung ventilation in
these patients. The main question is whether this is a desirable compensatory mechanism
or an impairment of optimal regulation. CO2 is a well known cerebral vasodilator whereas
hyperventilation leads to cerebral vasoconstriction. Therefore, hyperventilation can
prevent development of brain edema, but can also worsen cerebral ischemia. A remaining
question is whether mild hyperventilation resulting in lower pCO2 could contribute to the
development of cerebral vasospasm and delayed cerebral ischemia. This observation can
bring up a question of changing the sedation protocol in patients with SAH to prevent
spontaneous hyperventilation. In the case where this is a favorable compensatory
mechanism, mild hyperventilation during general anesthesia could be an option. Further
studies are needed to clarify these dilemmas.
The study is designed to identify potential biomarkers of cerebral ischemia, which could
eventually be used in clinical practice. The number of patients enrolled in the study is big
enough to detect a precise and reliable biomarker which is sensitive and specific enough to
have significant predictive power. The majority of similar studies that tested biomarkers
in patients with SAH had even smaller numbers of patients. The weakness of this study is
that the observed patient population was not that severely ill as the other studied
populations operated on for cerebral aneurysm with SAH. The lack of the most severe
cases, with severe pathophysiologic derangement and unfavorable outcome, can hide
potential differences between patients operated on electively and those operated on after
aneurismal rupture. The same can be assumed for the potential difference between those
with a favorable outcome, without any sequel, and those with some, but in general rather
mild,neurologic impairment. In our study, the Hunt Hess score in the observed
population of patients with a ruptured aneurysm was low, so a favorable outcome was
expected. For example, in the study of Siman et al, the average Hunt Hess score was 2.6
compared to 1.48 in our study. (51) In the study of Mascia et al, 6 of 20 patients had GCS
of less than 8. (52) In other words, discrete brain lesions did not cause great
pathophysiological derangement which could lead to significant production of potential
biomarkers like endothelin-1. Similar could be assumed for concentrations of lactate,
since mild regional ischemia cannot produce enough detectable lactate in blood samples.
Only significant brain ischemia with significant number of brain cells switched to
anaerobic metabolism could result in detectable lactate production, which could be
confirmed by measuring the venoarterial difference in blood lactate concentrations. For
this purpose, venous samples are obtained from the jugular vein, which contains blood
coming directly from the brain.
We can conclude that despite some interesting positive results of statistical tests and
possibilities of explaining them according to pathophysiological principles of cerebral
vasospasm and ischemia, this study did not demonstrate that lactate, blood gases and
endothelin-1, analysed in arterial blood and venous blood coming from the brain, could
serve as reliable and useful clinical markers or powerful predictors of delayed cerebral
ischemia in everyday clinical practice.
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GOS, Glasgow outcome scale; P, statistical probability; SAH, subarachnoid hemorrhage;
SD, standard deviation.
Table 2. Potential biomarkers compared between the group of patients with a favorable















Endothelin 1 in artery next
morning (fmol/mL) 0,08 0,05 0,14 0,07 0,05 0,13 -0,192 0,848
Endothelin 1 in vein next morning
(fmol/mL) 0,07 0,04 0,13 0,13 0,04 0,32 -1,309 0,190
Endothelin 1veno arterial
difference next morning (fmol/L) -0,02 -0,05 0,03 0,03 -0,02 0,18 -2,122 0,034
pCO2 in jugular vein before
aneurismal clamping (kPa)
6,0 5,3 6,5 6,4 6,0 7,3 -1,960 0,050
pCO2 in jugular vein 5 minutes
after aneurismal clamping (kPa) 6,0 5,2 6,5 6,5 6,0 6,9 -2,196 0,028
pCO2 in artery 30 minutes after
aneurismal clamping (kPa)
4,5 4,1 5,1 4,8 4,7 5,3 -2,057 0,040
pCO2 in jugular vein 30 minutes
after aneurismal clamping (kPa)
6,0 5,3 6,4 6,4 6,0 6,9 -2,348 0,019
pCO2 in artery after arrival in ICU
(kPa)
4,4 4,3 4,8 5,2 4,7 5,5 -2,340 0,019
pCO2 in jugular vein after arrival
in ICU (kPa)
5,6 5,2 5,9 6,2 5,7 6,7 -2,065 0,039
C, median; ICU, intensive care unit; P, statistical probability; pCO2, partial pressure of
carbon dioxide; Z,Mann Whitney test value.
Table 3. Correlation between lactate, pCO2 in arterial and jugular vein blood and GCS












































































































































































































































































































































































































































































































































































































































































GCS, Glasgow Coma Score; Hunt Hess, Hunt Hess score; P, statistical probability; pCO2,
partial pressure of carbon dioxide; rS, Spearman’s correlation coefficient. 
** Correlation is significant at the 0.01 level 
* Correlation is significant at the 0.05 level
Table 4. Correlation between endothelin-1 and lactate concentrations.
ALL PATIENTS rS P
Endothelin-1 in arterial blood before the operation and
,429 ,005
lactate in arterial blood before the operation
Endothelin-1 in arterial blood before the operation and
lactate in arterial blood 5 minutes after aneurismal clamping ,484 ,001
Endothelin-1 in arterial blood before the operation and
lactate in jugular vein blood 5 minutes after aneurismal clamping ,479 ,002
Endothelin-1 in arterial blood before the operation and
lactate in arterial blood 30 minutes after aneurismal clamping ,476 ,002
Endothelin-1 in arterial blood before the operation and
lactate in jugular vein blood 30 minutes after aneurismal clamping ,465 ,002
Endothelin-1 venoarterial concentration difference before the operation
and
lactate venoarterial concentration difference 30 minutes after aneurismal
clamping
-,449 ,003
Endothelin-1 in artery next day after the operation and arterial lactate after
the operation at arrival in ICU ,536 ,000
Endothelin-1 in artery next day after the operation and jugular vein lactate
after the operation at arrival in ICU ,519 ,001
PATIENTS WITH RUPTURED ANEURYSM rS P
Endothelin-1 in arterial blood before the operation and Endothelin-1 in
arterial blood during induction of anesthesia,
Lactate venoarterial concentration difference before the operation
-.593 ,003
Endothelin-1 in jugular vein 30 minutes after aneurismal clamping and
arterial blood lactate on the day after the operation ,596 ,003
Endothelin-1 in jugular vein blood 30 minutes after aneurismal clamping
and lactate in jugular vein blood on the day after the operation ,669 ,000
ICU, intensive care unit; P, statistical probability; rS, Spearman’s correlation coefficient.
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